According to a study, a class of diabetes medications may be linked to a decreased risk of dementia and Parkinson’s disease. The findings were published in the online edition of Neurology, the medical ...
Diabetes medications, specifically sodium-glucose cotransporter-2 (SGLT2) inhibitors, may be linked to a decreased risk of ...
A specific class of diabetes drug appears to lower people's risk for dementia and Parkinson's disease, a new study shows.
Researchers have found that people who take a type of type 2 diabetes drugs SGLT2 inhibitors have a significantly lower risk ...
A specific class of diabetes drug appears to lower people’s risk for dementia and Parkinson’s disease, a new study ...
Sodium-glucose cotransporter-2 (SGLT2) inhibitors, a class of diabetes drugs also known as gliflozins, could lower the risk ...
A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson's disease, according to a study ...
Scientists found a 22 percent lower risk of any dementia and Parkinson's among a group taking SGLT2 inhibitors for type 2 ...
A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson's disease, according to a study ...
According to a new study, certain diabetes medications may significantly reduce this risk. These drugs, called gliflozins or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback